Yoshiga D, Nakamichi I, Yamashita Y, Yamamoto N, Yamauchi K, Nogami S,
et al. Prognosis factors in the treatment of bisphosphonate-related
osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ -. J
Clin Exp Dent. 2014;6(1):e22-8.
doi:10.4317/jced.51213
References
1.
Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. Task
Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association
of Oral and Maxillofacial Surgeons. American Association of Oral and
Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis
of the jaw --2009 update. J Oral Maxillofac Surg. 2009;35:119-30.
2.
Ruggiero SL, Carlson ER, Assael LA. Comprehensive review of bisphosphonate
therapy: Implications for the oral and maxillofacial surgery patient. J Oral
Maxillofac Surg. 2009;67:1.
http://dx.doi.org/10.1016/j.joms.2009.03.001
PMid:19371808
3. Chapurlat R, Delmas PD. New
treatments in osteoporosis. Rev Med Interne 25 Suppl. 2004;25:S573-579.
PMid:15841950
4.
Marx RE. Pamidronate (aredia) and zoledronate (zometa) induced avascular
necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg.
2003;61:1115-7.
http://dx.doi.org/10.1016/S0278-2391(03)00720-1
PMid:12966493
5.
Erkan M, Bilgi O, Mutluoglu M, Uzun G. Bisphosphonate-related osteonecrosis of
the jaw in cancer patients and hyperbaric oxygen therapy. JOP. 2009;10:579-80.
PMid:19734644
6.
Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T,
Ikebe T, Kitagawa Y, Fukuta J. Nationwide survey for bisphosphonate-related
osteonecrosis of the jaws in japan. J Oral Maxillofac Surg. 2011;69:e364-71.
http://dx.doi.org/10.1016/j.joms.2011.03.051
PMid:21782307
7.
Mirzai R, Chang C, Greenspan A, Gershwin ME. The pathogenesis of osteonecrosis
and the relationships to corticosteroids. J Asthma.1999;36:77-95.
http://dx.doi.org/10.3109/02770909909065152
PMid:10077138
8.
Kuehn BM. Reports of adverse events from bone drugs prompt caution. JAMA.
2006;295:2833-6.
http://dx.doi.org/10.1001/jama.295.24.2833
PMid:16804139
9.
Diniz-Freitas M, L—pez-Cedrœn JL, Fern‡ndez-Sanrom‡n J, Garc’a-Garc’a A,
Fern‡ndez-Feijoo J, Diz-Dios P. Med Oral Patol Oral Cir Bucal. 2012;17:751-8.
http://dx.doi.org/10.4317/medoral.18041
PMCid:PMC3482517
10.
Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of
bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral
Maxillofac Surg. 2007;65:415-23.
http://dx.doi.org/10.1016/j.joms.2006.10.061
PMid:17307586
11.
Marx RE. Reconstruction of defects caused by bisphosphonate-induced
osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:107-9.
http://dx.doi.org/10.1016/j.joms.2008.12.007
PMid:19371821
12.
Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of
bisphosphonate-associated osteonecrosis of the jaws in australia. J Oral
Maxillofac Surg. 2007;65:415-23.
http://dx.doi.org/10.1016/j.joms.2006.10.061
PMid:17307586
13.
Regev E, Lustmann J, Nashef R. American association of oral and maxillofacial
surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J
Oral Maxillofac Surg 2007;65:369-76.
http://dx.doi.org/10.1016/j.joms.2006.11.003
PMid:17307580
14.
Regev E, Lustmann J, Nashef R. Atraumatic teeth extraction in
bisphosphonate-treated patients. J Oral Maxillofac Surg. 2008;66:1157-61.
http://dx.doi.org/10.1016/j.joms.2008.01.059
PMid:18486780
15.
Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of
the jaws: A review of 34 cases and evaluation of risk. J Craniomaxillofac Surg.
2010;8:255-9.
http://dx.doi.org/10.1016/j.jcms.2009.06.005
PMid:19592261
16.
Migliorati CA, Epstein JB, Abt E, Berenson JR. Osteonecrosis of the jaw and
bisphosphonates in cancer: A narrative review. Nat Rev Endocrinol.
2011;7:34-42.
http://dx.doi.org/10.1038/nrendo.2010.195
PMid:21079615
17.
Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum S, Pautke C.
Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk
factors, clinical features, localization and impact on oncological treatment. J
Craniomaxillofac Surg. 2012;40:303-9.
http://dx.doi.org/10.1016/j.jcms.2011.05.003
PMid:21676622
18.
Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N.
Bisphosphonate-related osteonecrosis of the jaws: A single-center study of 101
patients. J Oral Maxillofac Surg. 2009;67:850-5.
http://dx.doi.org/10.1016/j.joms.2008.11.015
PMid:19304045
19.
Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mucke T, Mast G,
Kohnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G,
Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD,
Sturzenbaum SR, Schieker M, Pautke C. Osteoporosis and bisphosphonates-related
osteonecrosis of the jaw: Not just a sporadic coincidence--a multi-centre
study. J Craniomaxillofac Surg. 2011;39:272-7.
http://dx.doi.org/10.1016/j.jcms.2010.05.009
PMid:20580566
20.
American Dental Association Council on Scientific Affairs. Dental management of
patients receiving oral bisphosphonate therapy: Expert panel recommendations. J
Am Dent Assoc. 2006;137:1144-50.
http://dx.doi.org/10.14219/jada.archive.2006.0355
PMid:16873332
21.
Kwon YD, Ohe JY, Kim DY, Chung DJ, Park YD. Retrospective study of two biochemical
markers for the risk assessment of oral bisphosphonate-related osteonecrosis of
the jaws: Can they be utilized as risk markers? Clin Oral Implants Res.
2011;22:100-5.
http://dx.doi.org/10.1111/j.1600-0501.2010.01965.x
PMid:20946206
22.
Worsfold M, Powell DE, Jones TJ, Davie MW. Assessment of urinary bone markers
for monitoring treatment of osteoporosis. Clinical Chemistry. 2004;50:2263-70.
http://dx.doi.org/10.1373/clinchem.2004.037424
PMid:15472034
23.
Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster
JY, Cooper C. Subtrochanteric fractures after long-term treatment with
bisphosphonates: A european society on clinical and economic aspects of
osteoporosis and osteoarthritis, and international osteoporosis foundation
working group report. Osteoporos Int. 2011;22:373-90.
http://dx.doi.org/10.1007/s00198-010-1453-5
PMid:21085935
PMCid:PMC3020314
24.
Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shuler CF. Oral
bisphosphonate use and the prevalence of osteonecrosis of the jaw: An
institutional inquiry. J Am Dent Assoc. 2009;140:61-6.
http://dx.doi.org/10.14219/jada.archive.2009.0019
PMid:19119168
25.
Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert
B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum SR, Kolk A.
Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of
the jaws: First clinical results of a prospective pilot study. J Oral
Maxillofac Surg. 2011;69:84-91.
http://dx.doi.org/10.1016/j.joms.2010.07.014
PMid:20971542